Skip to content

INDEPENDENT EQUITY RESEARCH

  • The Program
  • Reports
  • About Us
  • Contact us
  • The Program
  • Reports
  • About Us
  • Contact us
  • The Program
  • Reports
  • About Us
  • Contact us

INDEPENDENT EQUITY RESEARCH

Read more about the article RedHill Biopharma Ltd.: Strategic Expansion from R&D to Sales of Drugs in the US

RedHill Biopharma Ltd.: Strategic Expansion from R&D to Sales of Drugs in the US

  • Post author:jaimeuss_admin
  • Post published:17 בSeptember 2018
  • Post category:Research
  • Post comments:0 Comments

Continue ReadingRedHill Biopharma Ltd.: Strategic Expansion from R&D to Sales of Drugs in the US
Read more about the article BiolineRx. An Opportunity to Invest in the Development of Unique Cancer Treatment Technologies

BiolineRx. An Opportunity to Invest in the Development of Unique Cancer Treatment Technologies

  • Post author:jaimeuss_admin
  • Post published:30 בAugust 2018
  • Post category:Research
  • Post comments:0 Comments

Continue ReadingBiolineRx. An Opportunity to Invest in the Development of Unique Cancer Treatment Technologies
Read more about the article BioLineRx Ltd.: Additional Investment by A Principal Investor Reflects a Confidence in the Company. Target Price Unchanged

BioLineRx Ltd.: Additional Investment by A Principal Investor Reflects a Confidence in the Company. Target Price Unchanged

  • Post author:jaimeuss_admin
  • Post published:30 בAugust 2018
  • Post category:Research
  • Post comments:0 Comments

Continue ReadingBioLineRx Ltd.: Additional Investment by A Principal Investor Reflects a Confidence in the Company. Target Price Unchanged
INDEPENDENT EQUITY RESEARCH

Tel: +972(0)9.950.2888
Email: equity.research@frost.com

Contact us

Copyright © 2020 Frost & Sullivan. All Rights Reserved.   Privacy Policy.

Accessibility by WAH